InvestorsHub Logo
icon url

haysaw

05/16/10 5:12 PM

#33535 RE: Aiming4 #33534

I believe if they do the right thing, and it's transparent, then yes there will be more confidence (translation-a higher share price). This assumes they have a demostrated their drug candidates have decent potential, which I/we obviously believe is the case.
icon url

neuroinv

05/16/10 7:17 PM

#33536 RE: Aiming4 #33534

A contrary view: I would prefer for management to not buy shares now. Why? Because they can only buy shares if nothing is happening behind the scenes that would be material to the value of the shares. For example, during the drawn-out Biovail negotiations, they knew details of the transaction under discussion that would have made a stock purchase illegal. So I would still prefer that they not buy shares, because it at least leaves open the possibility that they are aware of something pertaining to the SA trial, or the sz/dep rights held by Merck, or something else entirely---that we don't know about. If they buy, it means nothing material is currently in play.

NeuroInvestment
icon url

Jads14

05/17/10 2:39 PM

#33554 RE: Aiming4 #33534

<So you believe if mgmt buys stock now, CORX will move to a higher base and stay there.

That seems completely unrealistic to me, but I respect your opinion.>


Could not agree more with you Aiming. CORX over the years has been a manipulated stock by the market maker and whether mgmt. buys 100K or whatever will not matter. Today is just another example of the manipulation. Stk. on some 56,000 sh. is at .214 then 3,500 sh. are traded at .184.